Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1305
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02171078 | Post-Treatment Surveillance in Breast Cancer: Bringing CER to the Alliance | ||
| NCT00556049 | Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma | ||
| NCT02523040 | Lenalidomide for Adult Histiocyte Disorders | ||
| NCT01510418 | Socialization of Adult Men With Congenital Hemophilia A or B | ||
| NCT00429910 | Natural History Study of Patients With Chronic Myelogenous Leukemia | ||
| NCT00123825 | Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer | ||
| NCT01476462 | Second Malignant Neoplasms After Childhood ALL Therapy | ||
| NCT00134641 | Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas | ||
| NCT00788775 | Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma | ||
| NCT06463457 | Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED) | ||
| NCT06644183 | Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL) | ||
| NCT01834183 | Tivozanib + Gemcitabine in Metastatic RCC | ||
| NCT05800366 | A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma | ||
| NCT00590902 | Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung Cancer | ||
| NCT03075527 | A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma | ||
| NCT00476086 | Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus | ||
| NCT06844383 | A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate | ||
| NCT03277469 | Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer | ||
| NCT01894451 | Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy | ||
| NCT00916630 | Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lymphoma With ALIMTA (Pemetrexed) | ||
| NCT00137800 | Study of OSI-774 (Tarceva) in Previously Untreated Elderly Lung Cancer Patients | ||
| NCT02764541 | Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS) | ||
| NCT03085719 | Targeting PD-1 Therapy Resistance With Focused High or High and Low Dose Radiation in SCCHN | ||
| NCT03858712 | EHR-embedded OCDT in Breast or GI Cancer | ||
| NCT00165230 | Thalidomide in Combination With Temodar in Patients With Neuroendocrine Tumors | ||
| NCT01674842 | Cisplatin + RT for Triple Negative Breast Cancer | ||
| NCT00230542 | Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer | ||
| NCT03899805 | A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas | ||
| NCT00005627 | Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | ||
| NCT00776594 | Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy | ||
| NCT06507930 | The COMPASSION Study | ||
| NCT03850912 | Symptom Management Implementation of Patient Reported Outcomes in Oncology | ||
| NCT05765500 | RecoverPC: Relugolix vs GnRH Agonist in Quality of Life | ||
| NCT00355407 | Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation | ||
| NCT02576444 | OLAParib COmbinations | ||
| NCT02335671 | Evaluating Mass Spectrometry And Intraoperative MRI In The Advanced Multimodality Image Guided Operating Suite (Amigo) In Breast-Conserving Therapy | ||
| NCT00997334 | Erlotinib Therapy and Subsequent Development of Mechanisms of Secondary Resistance in Patients With NSCLC | ||
| NCT00165516 | Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate | ||
| NCT00116506 | Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer | ||
| NCT00144677 | Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation | ||
| NCT00585507 | Efficacy and Safety of 500mg of Fulvestrant | ||
| NCT03835819 | A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC) | ||
| NCT03070145 | Exercise Intervention Among Men With Prostate Cancer Initiating Androgen Deprivation Therapy | ||
| NCT04305145 | Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis | ||
| NCT04660422 | Advance Care Planning: Communicating With Outpatients for Vital Informed Decision | ||
| NCT00874562 | Rapamycin in Relapsed Acute Lymphoblastic Leukemia | ||
| NCT00554515 | The High-Dose Aldesleukin (IL-2) "Select" Trial for Patients With Metastatic Renal Cell Carcinoma | ||
| NCT04997096 | Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy | ||
| NCT03122717 | Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer | ||
| NCT03683680 | Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers |
